Shares of BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) traded up 4.5% during mid-day trading on Tuesday . The company traded as high as $1.90 and last traded at $1.85. 13,494 shares changed hands during trading, a decline of 85% from the average session volume of 87,537 shares. The stock had previously closed at $1.77.
BeyondSpring Stock Performance
The stock’s 50-day moving average is $2.14 and its 200-day moving average is $2.23.
Hedge Funds Weigh In On BeyondSpring
A hedge fund recently bought a new stake in BeyondSpring stock. SG Americas Securities LLC purchased a new stake in BeyondSpring Inc. (NASDAQ:BYSI – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 17,539 shares of the company’s stock, valued at approximately $63,000. 40.29% of the stock is owned by hedge funds and other institutional investors.
About BeyondSpring
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Further Reading
- Five stocks we like better than BeyondSpring
- How to Capture the Benefits of Dividend Increases
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- How to Buy Cheap Stocks Step by Step
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Investing in Commodities: What Are They? How to Invest in Them
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
